Severity
Moderate
ModerateClass IIOngoing
FDA Drug recall · Reported April 15, 2026
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch
CGMP Deviations: use of an unapproved raw material
The recall
Teva Pharmaceuticals USA, Inc issued this moderate-severity FDA Drug recall — CGMP Deviations: use of an unapproved raw material.
- Moderate
- severity level
- Class II
- classification
- April 15, 2026
- reported
Sourced from official FDA Drug enforcement records. Verify recall #D-0474-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This FDA Drug action (record #D-0474-2026) was formally reported on April 15, 2026, with the manufacturer initiating the action on March 19, 2026. It is classified under Moderate severity (Class II), with a current status of Ongoing. Teva Pharmaceuticals USA, Inc is listed as the recalling firm, operating out of Parsippany, NJ. Federal records list the affected scope as 113,943 Cartons.
The documented reason for this recall is: CGMP Deviations: use of an unapproved raw material Distribution data in the federal record shows the product reached: Within U.S. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 4 from FDA Drug — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Vehicles recalls over time
Where this recall sits in its category — 9,301 vehicles recalls on record
Where this recall sits in the database
Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.
Affected scope
113,943 Cartons
Related Recalls
6
4 from same agency
Product description
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch
Reason for recall
CGMP Deviations: use of an unapproved raw material
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0474-2026 |
| Date reported | April 15, 2026 |
| Date initiated | March 19, 2026 |
| Recalling firm | Teva Pharmaceuticals USA, Inc |
| Firm location | Parsippany, NJ |
| Affected scope | 113,943 Cartons |
| Distribution | Within U.S |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (D-0474-2026) and product description against the item you own. Search the archive
- Confirm the current status with FDA Drug before acting — recall details can be updated.
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch. Recalled by Teva Pharmaceuticals USA, Inc. Units affected: 113,943 Cartons.
Why was this product recalled? ▼
CGMP Deviations: use of an unapproved raw material
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on April 15, 2026. Severity: Moderate. Recall number: D-0474-2026.
Where was the recalled product distributed? ▼
Distribution: Within U.S.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (D-0474-2026) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device? ▼
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.
Continue exploring
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
FDA Drug recalls
Every recall issued by FDA Drug, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Nearby Recalls in This Category
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
FDA Drug Moderate
Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distributed by: Haleon, Warren, NJ 07059, UPC: 3 00674 35041 9.
Haleon US Holdings LLC · 2026-05-27
FDA Food Low
Garland Fresh Peeled Garlic 6 oz. bag
Tops Markets LLC · 2026-05-13
FDA Food Low
Christopher Ranch Peeled Garlic 6 oz.
Tops Markets LLC · 2026-05-13
FDA Drug Moderate
BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 0.36 f…
CareFusion 213, LLC · 2026-05-13
FDA Drug Moderate
BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 25x26m…
CareFusion 213, LLC · 2026-05-13
Compare this recall with Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distribut… →
Data Sources
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported April 15, 2026.
- Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
- Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
- Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.